Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$31.02 - $48.18 $930,600 - $1.45 Million
-30,000 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$41.14 - $56.98 $1.23 Million - $1.71 Million
30,000 New
30,000 $1.4 Million
Q3 2020

Nov 13, 2020

SELL
$27.5 - $39.61 $1.38 Million - $1.98 Million
-50,000 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$36.1 - $42.56 $1.81 Million - $2.13 Million
50,000 New
50,000 $2.13 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.